annual EBITDA:
-$157.24M-$54.76M(-53.43%)Summary
- As of today (August 29, 2025), GPCR annual EBITDA is -$157.24 million, with the most recent change of -$54.76 million (-53.43%) on December 31, 2024.
- During the last 3 years, GPCR annual EBITDA has fallen by -$119.61 million (-317.91%).
- GPCR annual EBITDA is now -888.53% below its all-time high of -$15.91 million, reached on December 1, 2020.
Performance
GPCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$70.16M-$14.12M(-25.20%)Summary
- As of today (August 29, 2025), GPCR quarterly EBITDA is -$70.16 million, with the most recent change of -$14.12 million (-25.20%) on June 30, 2025.
- Over the past year, GPCR quarterly EBITDA has dropped by -$37.08 million (-112.07%).
- GPCR quarterly EBITDA is now -444.64% below its all-time high of -$12.88 million, reached on March 1, 2022.
Performance
GPCR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$218.56M-$37.08M(-20.43%)Summary
- As of today (August 29, 2025), GPCR TTM EBITDA is -$218.56 million, with the most recent change of -$37.08 million (-20.43%) on June 30, 2025.
- Over the past year, GPCR TTM EBITDA has dropped by -$96.69 million (-79.34%).
- GPCR TTM EBITDA is now -1554.72% below its all-time high of -$13.21 million, reached on December 1, 2021.
Performance
GPCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GPCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.4% | -112.1% | -79.3% |
| 3 y3 years | -317.9% | -404.7% | -446.5% |
| 5 y5 years | -888.5% | -431.2% | -1554.7% |
GPCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -317.9% | at low | -444.6% | at low | -451.0% | at low |
| 5 y | 5-year | -888.5% | at low | -444.6% | at low | -1554.7% | at low |
| alltime | all time | -888.5% | at low | -444.6% | at low | -1554.7% | at low |
GPCR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$70.16M(+25.2%) | -$218.56M(+20.4%) |
| Mar 2025 | - | -$56.04M(+19.8%) | -$181.48M(+15.4%) |
| Dec 2024 | -$157.24M(+53.4%) | -$46.79M(+2.7%) | -$157.24M(+11.2%) |
| Sep 2024 | - | -$45.57M(+37.7%) | -$141.37M(+16.0%) |
| Jun 2024 | - | -$33.08M(+4.1%) | -$121.86M(+6.3%) |
| Mar 2024 | - | -$31.79M(+2.8%) | -$114.69M(+11.9%) |
| Dec 2023 | -$102.48M | -$30.92M(+18.6%) | -$102.48M(+21.4%) |
| Sep 2023 | - | -$26.07M(+0.6%) | -$84.44M(+44.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$25.91M(+32.4%) | -$58.38M(+25.9%) |
| Mar 2023 | - | -$19.58M(+52.0%) | -$46.36M(+16.9%) |
| Dec 2022 | -$52.28M(+39.0%) | -$12.88M(-7.3%) | -$39.67M(-0.8%) |
| Jun 2022 | - | -$13.90M(+7.9%) | -$39.99M(+53.3%) |
| Mar 2022 | - | -$12.88M(-2.5%) | -$26.09M(+97.5%) |
| Dec 2021 | -$37.62M(+136.5%) | - | - |
| Dec 2021 | - | -$13.21M | -$13.21M |
| Dec 2020 | -$15.91M | - | - |
FAQ
- What is Structure Therapeutics Inc. annual EBITDA?
- What is the all time high annual EBITDA for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. annual EBITDA year-on-year change?
- What is Structure Therapeutics Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. quarterly EBITDA year-on-year change?
- What is Structure Therapeutics Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. TTM EBITDA year-on-year change?
What is Structure Therapeutics Inc. annual EBITDA?
The current annual EBITDA of GPCR is -$157.24M
What is the all time high annual EBITDA for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high annual EBITDA is -$15.91M
What is Structure Therapeutics Inc. annual EBITDA year-on-year change?
Over the past year, GPCR annual EBITDA has changed by -$54.76M (-53.43%)
What is Structure Therapeutics Inc. quarterly EBITDA?
The current quarterly EBITDA of GPCR is -$70.16M
What is the all time high quarterly EBITDA for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high quarterly EBITDA is -$12.88M
What is Structure Therapeutics Inc. quarterly EBITDA year-on-year change?
Over the past year, GPCR quarterly EBITDA has changed by -$37.08M (-112.07%)
What is Structure Therapeutics Inc. TTM EBITDA?
The current TTM EBITDA of GPCR is -$218.56M
What is the all time high TTM EBITDA for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high TTM EBITDA is -$13.21M
What is Structure Therapeutics Inc. TTM EBITDA year-on-year change?
Over the past year, GPCR TTM EBITDA has changed by -$96.69M (-79.34%)